Authors: Stockschlader, M Exner, S Schmah, O Finke, J

Citation: M. Stockschlader et al., Expansion and fibronectin-enhanced retroviral transduction of primary human T lymphocytes for adoptive immunotherapy, HEMAT BLOOD, 40, 2001, pp. 291-306

Authors: Clausen, J Stockschlader, M Fehse, N Hassan, HT Gabl, C Zander, AR

Citation: J. Clausen et al., Blood-derived macrophage layers in the presence of hydrocortisone support myeloid progenitors in long-term cultures of CD34(+) cord blood and bone marrow cells, ANN HEMATOL, 79(2), 2000, pp. 59-65

Authors: Zeller, W Kroger, N Berger, J Krueger, W Dierlamm, J Stockschlader, M Gutensohn, K Hossfeld, DK Zander, AR

Citation: W. Zeller et al., Expression of the adhesion molecules CD49d and CD49e on G-CSF-mobilized CD34(+) cells of patients with solid tumors or non-Hodgkin's and Hodgkin's lymphoma and of healthy donors is inversely correlated with the amount of mobilized CD34(+) cells, J HEMATH ST, 8(5), 1999, pp. 539-546

Authors: Stockschlader, M Haiss, M Exner, S Schmah, O Veelken, H Follo, M Ruger, R Finke, J

Citation: M. Stockschlader et al., Expansion and fibronectin-enhanced retroviral transduction of primary human T lymphocytes for adoptive immunotherapy, J HEMATH ST, 8(4), 1999, pp. 401-410

Authors: Zander, AR Zabelina, T Kroger, N Renges, H Kruger, W Loliger, C Durken, M Stockschlader, M de Wit, M Wacker-Backhaus, G Bielack, S Jaburg, N Russmann, B Erttmann, R Kabisch, H

Citation: Ar. Zander et al., Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow, BONE MAR TR, 23(9), 1999, pp. 889-893

Authors: Kroger, N Kruger, W Wacker-Backhaus, G Hegewisch-Becker, S Stockschlader, M Fuchs, N Russmann, B Renges, H Durken, M Bielack, S de Wit, M Schuch, G Bartels, H Braumann, D Kuse, R Kabisch, H Erttmann, R Zander, AR

Citation: N. Kroger et al., Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia, BONE MAR TR, 22(11), 1998, pp. 1029-1033